Hafsa Mahrukh

Hafsa Mahrukh

Auto-generated profile, based on publicly available information

Hafsa Mahrukh

250 Bedded General Hospital Thakurgaon Bangladesh

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
Md Shahed-MorshedMd Shahed-Morshed
Md Shahed-Morshed
HBHurjahan Banu
Hurjahan Banu
SHShamim Hossan
Shamim Hossan
HMHafsa Mahrukh
Hafsa Mahrukh
MHMuhammad Abul Hasanat
Muhammad Abul Hasanat
Objective: We compared various adiposity indices (AIs)—body mass index (BMI), waist circumference (WC), visceral adiposity index (VAI), lipid accumulation product, and the triglyceride-glucose (TyG), TyG-BMI, and TyG-WC indices—regarding their associations with insulin resistance (IR) among women with polycystic ovary syndrome (PCOS).Methods: This cross-sectional investigation included 632 reproductive-aged women with PCOS, aligning with the 2018 International Evidence-based Guideline. Clinical characteristics, including height, weight, and WC, were recorded. Fasting blood samples were analyzed to measure insulin, lipid, and glucose levels. AIs were then calculated using these measurements along with various formulas. The homeostatic model assessment for IR was utilized, with a value of 2.6 or higher indicating IR. An area under the curve (AUC) above 0.8 was considered clinically useful.Results: Approximately 69.1% of participants exhibited IR. All AIs were significant predictors of IR, regardless of androgen status. VAI and the TyG index were identified as poor markers of IR among women with PCOS (AUC, 0.6 to 0.69), while the remaining indices were considered fair markers (AUC, 0.7 to 0.79). VAI underperformed all other AIs except the TyG index, which was notably inferior to the TyG-BMI and TyG-WC indices. Nevertheless, the AUCs of TyG-BMI and TyG-WC were similar to those of BMI and WC.Conclusion: Although AIs exhibit androgen-independent relationships with IR, their usefulness as indicators of IR in PCOS is not adequately supported by our results (AUC <0.8). Furthermore, combining the TyG index with BMI and WC does not significantly improve the diagnostic utility of IR.

16 January 2026 in Reproductive Medicine and Biology
Verified
Journal Article
Open access
Md Shahed-MorshedMd Shahed-Morshed
Md Shahed-Morshed
MHMashfiqul Hasan
Mashfiqul Hasan
TTTania Tofail
Tania Tofail
HBHurjahan Banu
Hurjahan Banu
NSNusrat Sultana
Nusrat Sultana
MHMuhammad Abul Hasanat
Muhammad Abul Hasanat
Purpose: This cross‐sectional survey aimed to determine the prevalence and characteristics of polycystic ovary syndrome (PCOS) and its isolated diagnostic features among Bangladeshi women aged 10–45 years, utilizing the 2023 International Evidence‐Based Guidelines, incorporating anti‐Mullerian hormone (AMH). Methods: From April–September 2024, 1201 females were sampled across eight divisions of Bangladesh using history, physical examinations, and blood collection. Total testosterone (TT) and AMH levels were assessed, with specific cut‐offs established from a healthy control group. Thyroid dysfunction and hyperprolactinemia were excluded. Results: Of 1201 participants, 403 were excluded. Among 798 eligible women, 38 (4.8%) had both irregular cycles and significant hirsutism, 75 (9.4%) had only significant hirsutism, 141 (17.7%) had only irregular cycles, and 544 (68.2%) had neither. After TT and AMH evaluation and excluding two hyperprolactinemia cases, a 6.9% (55/798) prevalence was found among 57 women with probable PCOS. Familial predisposition, unhealthy sleep behavior, and higher androgenic and metabolic features were observed in women with PCOS versus controls. Metabolic syndrome frequency was higher among adult PCOS (33.3% vs. 4.0%) than adolescent PCOS. Conclusions: The prevalence of PCOS among Bangladeshi women was 6.9%, with distinctive features compared to controls. Women with isolated diagnostic criteria require further evaluation and long‐term follow‐up.

29 October 2025 in Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
Verified
Journal Article
Open access
PDF file
SISamirah Binte Illiyas
Samirah Binte Illiyas
Md Shahed-MorshedMd Shahed-Morshed
Md Shahed-Morshed
MHMashfiqul Hasan
Mashfiqul Hasan
TTTania Tofail
Tania Tofail
HBHurjahan Banu
Hurjahan Banu
MHMuhammad Abul Hasanat
Muhammad Abul Hasanat
Background: Data regarding the nationwide prevalence of polycystic ovary syndrome (PCOS) in Bangladeshi women is scarce. Additionally, a prevalence study using the stepwise decision-making approach, incorporating antimüllerian hormone (AMH), was also not reported. Objectives: To determine the prevalence and characteristics of PCOS and its isolated diagnostic features among Bangladeshi women aged 10-45 years, using the 2023 International Evidence-based Guidelines, including AMH. Methods: From April to September 2024, 1201 females were sampled across eight divisions of Bangladesh by history, physical examinations, and blood collection. Total testosterone (TT) and AMH levels were assessed, with specific cut-offs established from a healthy control group. Thyroid dysfunction and hyperprolactinemia were excluded. Results: Of 1201 participants, 403 were excluded. Among 798 eligible women, 38 (4.8%) had both irregular cycles and significant hirsutism, 75 (9.4%) had only significant hirsutism, 141 (17.7%) had only irregular cycles, and 544 (68.2%) had neither. After TT and AMH evaluation and excluding two hyperprolactinemia cases, a 6.9% (55/798) prevalence was found among 57 women with probable PCOS. Familial predisposition, unhealthy sleep behaviour, and higher androgenic and metabolic features were observed in women with PCOS versus controls. Metabolic syndrome frequency was higher among adult PCOS (33.3% vs. 4.0%) than adolescent PCOS. Conclusions: The prevalence of PCOS among Bangladeshi women was 6.9%, with distinctive features compared to controls. Women with isolated diagnostic criteria require further evaluation and long-term follow-up. [J Assoc Clin Endocrinol Diabetol Bangladesh, 2025;4(Suppl 1): S37]